Opthocare PD (Moxifloxacin 0.5% + Prednisolone 1%) is a dual-action ophthalmic solution designed to combat bacterial infections while reducing chronic inflammation. Combining the broad-spectrum antibacterial properties of Moxifloxacin with the anti-inflammatory efficacy of Prednisolone, it provides comprehensive care for mixed bacterial infections, chronic infections, and inflammation. Ideal for cases where monotherapy is insufficient, Opthocare PD ensures effective management of mixed eye infections, promoting faster recovery and better ocular health.
Mixed bacterial infection
Chronic infection & inflammation
Uncontrolled eye infection with monotherapy
Mixed eye infection
Opthocare PD is available in a single, optimized formulation combining Moxifloxacin 0.5% and Prednisolone 1% to provide comprehensive treatment for both bacterial infections and chronic ocular inflammation. The dual-action approach targets both the infection at the DNA replication level and reduces inflammation, ensuring effective management of mixed infections and chronic conditions. The single variation simplifies treatment, offering an efficient, all-in-one solution that minimizes the need for multiple therapies, making it the best choice for complex eye infections and inflammation.
Opthocare PD contains Moxifloxacin, a fourth-generation fluoroquinolone, which effectively inhibits bacterial DNA gyrase and topoisomerase IV. This dual inhibition prevents bacterial DNA replication, leading to the rapid elimination of a broad spectrum of gram-positive and gram-negative bacteria, making it highly effective for mixed bacterial eye infections.
Prednisolone, a corticosteroid, works by suppressing inflammation and immune response in the ocular tissues. It reduces swelling, redness, and discomfort, making Opthocare PD particularly effective in managing chronic eye infections and inflammation, ensuring better recovery and reduced risk of recurrence.
The combination of Moxifloxacin and Prednisolone provides a synergistic effect, addressing both the infectious and inflammatory components of mixed eye infections. This dual therapy enhances treatment outcomes, especially in cases where monotherapy alone may be insufficient, providing a comprehensive solution for uncontrolled and chronic infections.
Q
What is Opthocare PD used for?
A
Opthocare PD is an ophthalmic solution used to treat mixed bacterial infections and chronic eye infections, while also reducing inflammation in conditions like uncontrolled infections and chronic ophthalmic inflammation.
Q
How does Opthocare PD work?
A
Opthocare PD combines Moxifloxacin, a broad-spectrum antibiotic that inhibits bacterial DNA replication, with Prednisolone, an anti-inflammatory corticosteroid, providing dual action to treat both infections and inflammation in the eye.
Q
Can Opthocare PD be used for mixed eye infections?
A
Yes, Opthocare PD is specifically formulated to treat mixed eye infections, effectively targeting both the bacterial infection and the associated inflammation, ensuring comprehensive treatment.
